AstraZeneca PLC (AZN) Investment Research Dashboard
About AstraZeneca PLC (AZN) stock analysis
Get live AZN stock price $172.48, comprehensive AstraZeneca PLC stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time AZN stock data and investment insights.
Loading chart data...
AstraZeneca PLC (AZN) Overview
AstraZeneca PLC (AZN) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, AZN trades at $172.48 with a market capitalization of 133.67B . Over the past 52 weeks, AZN has traded between $145.14 and $212.71 , with the current price positioned at approximately 40% of this range . The stock current...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 133.67B
- Current price: $172.48
- 52-week range: $145.14 - $212.71
- P/E ratio: 18.63
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's exten...
Company Information
- CEO
- Pascal Claude Roland Soriot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 96100
Contact Information
- Website
- https://www.astrazeneca.com
- Address
- 1 Francis Crick Avenue
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 133.7 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 18.6)
✓ Lower volatility stock (Beta: 0.23) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for AstraZeneca PLC shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for AstraZeneca PLC
- ⚠Investors should consider how AstraZeneca PLC fits within their overall portfolio allocation
Market Cap
133.67B
P/E Ratio (TTM)
18.63
Beta
0.23
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare AZN with peer companies:
- Price
- $263.48+2.56% (1D)
- Market cap
- 465.51B
- Price
- $393.10+4.48% (1D)
- Market cap
- 212.16B
- Price
- $63.60+1.66% (1D)
- Market cap
- 129.88B
- Price
- $134.32+2.91% (1D)
- Market cap
- 166.77B
- Price
- $53.71+3.33% (1D)
- Market cap
- 108.36B
- Price
- $266.73+0.29% (1D)
- Market cap
- 642.79B
- Price
- $1,222.61+2.09% (1D)
- Market cap
- 1.15T
- Price
- $131.84+0.82% (1D)
- Market cap
- 325.61B
- Price
- $159.85+2.40% (1D)
- Market cap
- 303.83B
- Price
- $25.25+2.35% (1D)
- Market cap
- 143.91B
- Price
- $56.52+3.20% (1D)
- Market cap
- 360.27B
- Price
- $45.54+3.50% (1D)
- Market cap
- 110.48B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.